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http://dx.doi.org/10.1016/j.stemcr.2016.12.022SUMMARYEstrogen stimulates breast development during puberty and mammary tumors in adulthood through estrogen receptor-a (ERa). These
effects are proposed to occur via ERa+ luminal cells and not the mammary stem cells (MaSCs) that are ERaneg. Since ERa+ luminal
cells express stem cell antigen-1 (SCA-1), we sought to determine if SCA-1 could define an ERa+ subset of EpCAM+/CD24+/CD49fhi
MaSCs. We show that the MaSC population has a distinct SCA-1+ population that is abundant in pre-pubertal mammary glands.
The SCA-1+ MaSCs have less stem cell markers and less in vivo repopulating activity than their SCA-1neg counterparts. However, they
express ERa and specifically enter the cell cycle at puberty. Using estrogen-deficient aromatase knockouts (ArKO), we showed that
the SCA-1+ MaSC could be directly modulated by estrogen supplementation. Thus, SCA-1 enriches for an ERa+, estrogen-sensitive
subpopulation within the CD24+/CD49fhi MaSC population that may be responsible for the hormonal sensitivity of the developing
mammary gland.INTRODUCTION
Estrogen exposure has long been associated with breast
cancer (BCa) risk and early-life estrogen exposures can
have impacts many decades later (Warri et al., 2008; Clem-
ons and Goss, 2001). Estrogen is also important for normal
mammary gland development, with aromatase knockout
(ArKO) and estrogen receptor-a (ERa)-deficient mice
showing only rudimentary ductal structures (Fisher et al.,
1998; Hewitt et al., 2010). It was therefore surprising to
find that adult mouse mammary epithelial cells enriched
for mammary stem cell (MaSC) activity (CD24+ CD29hi/
CD24+ CD49fhi) were ERa negative (Asselin-Labat et al.,
2006). However, MaSCs are extremely sensitive to estro-
gens and progesterone, as evidenced by their loss with
ovariectomy and their increase during pregnancy (Asse-
lin-Labat et al., 2010). It is now accepted that MaSC
hormone sensitivity is mediated indirectly by the RANK/
RANKL axis (Asselin-Labat et al., 2010; Joshi et al., 2010;
Tanos et al., 2013).
Stem cell activity within the mammary gland was first
described using mammary fat pad transplants (Daniel
et al., 1968; Deome et al., 1959). Several investigatorsStem Cell R
This is an open access article under the Cthen used morphology to define these cells in tissue sec-
tions by nature of their small light appearance at the ultra-
structural level, or by their localization within the cap cells
of terminal end buds (TEBs) (Chepko and Smith, 1997;Wil-
liams and Daniel, 1983). More recent research has focused
on trying to determine the identity ofMaSCs using cell sur-
face markers. Stem cell antigen 1 (SCA-1) had been used to
isolate hematopoietic stem cells (HSCs) (Goodell et al.,
1996; Spangrude et al., 1988), and Welm et al. (2002) as-
sessed SCA-1 expression in the mammary gland. They
showed SCA-1 was highest in the mammary populations
that possessed in vivo stem cell activity. Following this
study, a combination of cell surface markers, also adapted
from the hematopoietic system, were used to enrich for
MaSCs, including heat stable antigen CD24 and either in-
tegrin beta-1 (CD29) or integrin alpha 6 (CD49f) or SCA-l
negativity (Asselin-Labat et al., 2006; Sleeman et al.,
2007). These markers led to a disagreement with the find-
ings of Welm et al. (2002) and the role of SCA-1 in MaSC
isolation has remained controversial.
Most recently, SCA-1 has been used to define ERa+
luminal mature cells and luminal progenitor cells within
the mammary gland (Sleeman et al., 2007; Shehata et al.,eports j Vol. 8 j 417–431 j February 14, 2017 j ª 2017 The Authors. 417
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Figure 1. The CD24+ CD49fhi Population Contains Both SCA-1+ and SCA-1neg Cells with the Proportions Changing with the Age of the
Mice
(A and B) FACS profiles from 3-week-old (A) and 6-week-old (B) mammary glands showing the CD24+ CD49fhi population that contains a
distinct subpopulation of SCA-1+ and negative cells.
(C–E) Changes in the percentage of CD24+ CD49fhi (C) cells present within the lineage negative population with age. Changes in the CD24+
CD49fhi SCA-1+ (D) and CD24+ CD49fhi SCA-1neg (E) cells with age. Graphs show means ± SEM. Statistical analysis completed by
nonparametric one-way ANOVA with the Dunn multiple comparisons post hoc test in GraphPad Prism. n = 4–11 pools of 20–30 animals.
*p < 0.05, **p < 0.01, ***p < 0.001.2012). To determine whether SCA-1 might identify a
similar population within the CD49fhi MaSC-enriched
population, we assessed the ERa transcript and protein
levels in the SCA-1+ and SCA-1neg CD49fhi cells. We also
sought to determine if this population of cells was respon-
sive to estrogen exposure.RESULTS
CD24+ CD49fhi SCA-1+ Cells Are Most Abundant in the
Young Mammary Gland
The CD24+ CD49fhi isolation strategy (Figure 1A) is a
superior MaSC isolation protocol compared with the use
of CD24lo SCA-1neg (Asselin-Labat et al., 2006; Sleeman
et al., 2007). The CD24+ CD49fhi population contains
both an SCA-1+ and SCA-1neg subset (Figures 1A and 1B).
Since MaSCs have been reported to be abundant in the
young breast (Russo and Russo, 1978a; Russo et al., 1982),418 Stem Cell Reports j Vol. 8 j 417–431 j February 14, 2017we analyzed the CD49fhi population for changes in
SCA-1 with increasing age, after separation based on
CD24 and CD49f. We used 4–11 independent pools, each
containing mammary tissue from 20 mice at each time
point to assess SCA-1+ cells with age. The total CD24+
CD49fhi population was least abundant in young mice
and increased with age (Figure 1C). The CD24+ CD49fhi
SCA-1+ subset was highly abundant in young mice
and decreased with age (Figure 1D). The CD24+ CD49fhi
SCA-1neg population followed the same trend as the parent
CD24+ CD49fhi population (Figure 1E).
To ensure that the SCA-1+ subset of CD24+ CD49fhi cells
was not contaminating SCA-1+ luminal cells, we assessed
epithelial lineages in Ly6A (SCA-1)-GFP mice (Alvi et al.,
2003). Using EpCAM and CD49f, which has recently
been shown to give similar results to CD24 and CD49f
(Shehata et al., 2012), both SCA-1+ and SCA-1neg cells
were detected within the EpCAM+ CD49fhi cells (Figures
S1A–S1C). We backgated the luminal and CD49fhi
populations and showed that they are indeed distinct (Fig-
ures S1D and S1E). The SCA-1+ luminal population showed
a distinct Ly6A-GFP population as expected. The CD24+
CD49fhi SCA-1+ subset also contained a Ly6A-GFP popula-
tion, but the SCA-1neg cells did not (Figures S1F–S1H).
Gene Expression Analysis Characterizes CD24+
CD49fhi SCA-1+ Cells
To determine the lineage of the CD24+ CD49fhi SCA-1+
and SCA-1neg cells, we assessed the expression of several
markers that have been directly or indirectly associated
with MaSC (Asselin-Labat et al., 2006; Bouras et al., 2008;
Kendrick et al., 2008; Cheng et al., 2000). These included
Lgr5 (a Wnt regulated target gene), a-SMA (a cytoskeletal
protein in basal cells, within which the stem cell popula-
tion resides), Id4 (inhibitor of DNA binding 4 that main-
tains the stem cell pool), p63 (a p53 gene family member
that regulates epithelial proliferation and differentiation),
Delta1, Fzd7, and Jag1 (notch receptor ligands). Jag1 has
been identified within MaSC (Asselin-Labat et al., 2006;
Kendrick et al., 2008; Cheng et al., 2000) and luminal cells
(Bouras et al., 2008). We assessed Hes1, which plays an
important role in the Notch signaling pathway (Kageyama
and Ohtsuka, 1999) and Mef2c, a transcription factor that
regulates cell fate decisions and is present in human and
mouse MaSC (Cheng et al., 2000) and long-term HSC (LT-
HSCs) (Ficara et al., 2008). Also included was Aldh1a1 (a
detoxifying enzyme responsible for the oxidation of intra-
cellular aldehydes) since it has been used as a BCa stem cell
(CSC) marker and is present in SCA-1+ CSC. We also as-
sessed the levels of luminal markers Keratin18, Notch1,
Hey 1, and Hey 2 and the luminal progenitor markers Elf5
and C-kit to determine if the SCA-1+ cells were progenitors
rather than stem cells per se. Finally, we assessed the levels
of the cell-cycle-related genes Cyclin D1 and Cyclin D2,
which have been associated with luminal and basal cell
populations, respectively (Joshi et al., 2010).
The CD24+ CD49fhi SCA-1neg cells expressed high levels
of stem cell markers Lgr5, a-SMA, Delta 1, Id4, Fzd7, p63,
and Aldh1a1 (Figure 2A). Consistent with this, Lgr5-GFP
mice showed Lgr5+ cells within the CD24+ CD49fhi SCA-
1neg population (Figure S2). In contrast, the CD24+ CD49fhi
SCA-1+ cells expressed only Delta 1 in high levels, with
moderate levels of p63 and Aldh1a1 (although these levels
were higher than those observed in the luminal subsets).
The CD24+ CD49fhi SCA-1+ cells had high Jag1 and Mef2c
levels compared with the low levels observed in CD24+
CD49fhi SCA-1neg cells. Hey1, Hey2, and Hes1 (notch target
genes) were all higher in the CD24+ CD49fhi SCA-1+ cells,
with some expression in the luminal cells. Expression
of the luminal-specific marker K18 was higher in the
CD24+CD49fhiSCA-1+ cells compared with the SCA-1neg
counterparts but lower than within the luminal popula-tions (Figure 2B). Curiously, the expression of K18 was
higher in CD24+ CD49fhi SCA-1+ cells at 3 compared with
6 weeks of age. Notch1 was higher in CD24+ CD49fhi
SCA-1+ cells compared with CD24+ CD49fhi SCA-1neg cells,
but appreciable levels were also observed in the luminal
cells (Figure 2B). As expected, Elf-5 and C-kit were highest
in the CD24+ CD49flo SCA-1neg (ERneg luminal) population
(Figure 2C). The CD24+ CD49fhi SCA-1+ cells expressed
higher levels of Elf5 and C-kit compared with the CD24+
CD49fhi SCA-1neg, although this was considerably lower
than in the luminal cells. Similar to previously published
results (Joshi et al., 2010), we found that Cyclin D1 was
higher in the luminal cells and Cyclin D2 was higher in
the MaSCs. The level of Cyclin D2 was slightly higher in
the CD24+ CD49fhi SCA-1+ MaSCs compared with the
CD24+ CD49fhi SCA-1neg subset. Thus, the CD24+CD49fhi
SCA-1+ cells are not specific to either the luminal or basal
lineage but rather express moderate levels of markers for
both.
SCA-1 Positivity Does Not Further Enrich CD24+
CD49fhi MaSCs for Stem Cell Activity
The in vivo stem cell activity of the SCA-1neg and SCA-1+
subsets of the CD24+ CD49fhi population was assessed us-
ing limiting dilution mammary fat pad transplants. Donor
mice were 6 weeks of age since, at this age, both popula-
tions are equally abundant (Figure 1). As shown in Figure 3,
there weremore positive outgrowths in the CD24+ CD49fhi
SCA-1neg cells (1:9,493, CI 5,377–16,761) compared with
the CD24+ CD49fhi SCA-1+ (1:25,902, CI 10,618–63,178)
(Figure 3A) equating to a 2.5-fold enrichment in stem cell
activity (p = 0.042). Both populations possessed multipo-
tent stem cell activity as they could generate all mammary
lineages (Figures 3B–3I). Sections of each outgrowth were
processed for H&E staining, ERa, and cytokeratin immuno-
staining to confirm that luminal, basal, and ERa+ epithelial
cells could be generated. The size of the outgrowths gener-
ated by both SCA-1+ and SCA-1neg cells was comparable
(Figure S3). In vitro mammosphere analysis confirmed a
2-fold enrichment in stem cell activity in the SCA-1neg
compared with SCA-1+ (Figures S4A–S4C). In contrast,
very little in vitro progenitor activity was observed from
either CD24+ CD49fhi SCA-1 subpopulation, as measured
by 2D colony-forming ability (Figures S4D–S4G).
SCA-1 Positivity Does Not Further Enrich CD24+
CD49fhi MaSC for Quiescent Cells
As the SCA-1+ subset of cells is abundant in the pre-pubertal
mammary gland and declines when estrogen-driven mam-
mary growth occurs, we reasoned these cells may represent
a quiescent stem cell pool. To investigate, this cell-cycle
activity was analyzed using Ki67 and Hoechst 33342 in 3-
and 6-week-old FVB/n mice (Cheng et al., 2000; MullallyStem Cell Reports j Vol. 8 j 417–431 j February 14, 2017 419
Figure 2. The SCA-1+ Subset Expresses
MaSC and Luminal Markers
TaqMan qPCR analysis of MaSC and luminal
markers in CD24+ CD49fhi SCA-1neg (pink
bars), CD24+ CD49fhi SCA-1+ (green bars),
CD24+ CD49flo SCA-1neg (dark gray bars),
and CD24+ CD49flo SCA-1+ (light gray bars).
Mean fold change ± SEM is shown relative
to 6 week CD24+ CD49fhi SCA-1neg sample
normalized to 1.
(A) Reported MaSC markers Lgr5, a-SMA,
Delta 1, Id4, Fzd7, p63, and Aldh1a1.
(B) Mixed lineage and luminal markers
Jag1, Mef2C, Hes1, Hey1, Hey2, Notch1, and
Keratin 18 as well as Cyclin D1 and Cylcin D2.
(C) Luminal progenitor markers Elf5 and
C-kit.
For all graphs n = 3 pools of 20–30 animals.
*p < 0.05, **p < 0.01.et al., 2013). As expected at 3 weeks of age, prior to the
onset of ductal growth in the mammary gland, the total
CD24+ CD49fhi MaSC population was predominantly in
G0 of the cell cycle (Figure 4A). The G0 and G1 gates were420 Stem Cell Reports j Vol. 8 j 417–431 j February 14, 2017set using fluorescence minus one (FMO) controls lacking
Ki67 (Figure S5). The luminal and nonepithelial popula-
tions were also predominantly quiescent at this age (data
not shown). At 6weeks of age, theCD24+ CD49fhi SCA-1neg
Figure 3. SCA-1 Does Not Enrich for In Vivo
MaSC Activity
(A) Limiting dilution mammary fat pad trans-
plant data from CD24+ CD49fhi SCA-1+ (SCA-1+)
and CD24+ CD49fhi SCA-1neg (SCA-1) cells. The
fractions denote the number of positive out-
growths as a percentage of the total number
of transplants. The percentage of positive out-
growths is given in brackets. Circles show
the filled proportion of the fat pad. Stem cell
enrichment was determined using the ELDA
program.
(B–I) Mammary outgrowths were assessed
using carmine-stained wholemount analysis
(B and F), H&E (C and G), ERa (D and H),
and CK14/CK18 immunostaining (E and I) to
confirm the architecture and presence of
cell lineages. Blue, DAPI; green, CK14; red,
CK18. Arrowheads in (D) and (H) show ERa-
positive cells; (B–E) show results from an
SCA-1+ outgrowth and (F–I) from an SCA-1neg
outgrowth.
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Figure 4. The CD24+ CD49fhi SCA-1+ Subset Is Highly Proliferative Compared with the SCA-1neg Subpopulation
Hoechst 33342 and Ki67 flow analysis of various MaSC populations at different ages.
(A–E) Representative analysis of total epithelial cells at 3 weeks of age (A). Representative analysis of CD24+ CD49fhi SCA-1neg population
(B) and of the CD24+ CD49fhi SCA-1+ population (C) at 6 weeks of age. Graphical representation of cell-cycle proportions of SCA-1neg and
SCA-1+ CD49fhi cells at 3 weeks of age (D) and 6 weeks of age (E). The SCA-1 and Ki67 gates were determined using fluorescence minus one
staining controls (Figure S5).population was predominantly arrested in the G1 check-
point, with a small percentage inG2/S/M stages (Figure 4B).
In contrast, the CD24+ CD49fhi SCA-1+ cells were predom-
inantly cycling (Figure 4C). Average values for three biolog-
ical replicate pools of 20 animals are shown for 3 weeks
(Figure 4D) and 6 weeks (Figure 4E). Together, these data
indicate that SCA-1 does not enrich for a quiescent popula-
tion of cells within the CD24+ CD49fhi population but
instead enriches for a population of cells that is specifically
activated to enter into the cell cycle at puberty.
TEBs Are Enriched for SCA-1+ Cells
To assess whether this specific activation of mitotic activity
in SCA-1+ subset was due to their involvement of TEB
proliferation, the proportion of CD24+CD49fhiSCA-1+
and SCA-1neg cells in TEBs was assessed (Figure 5). Using
a gentle dissociation, TEBs were specifically isolated (Fig-
ure 5A) and enzymatically digested to single cells and
analyzed by flow cytometry (Figure 5B). Ducts were isolated
and processed in a similar manner for comparison (Fig-
ure 5C), as were the TEB and duct-depleted samples (Fig-
ure 5D).Within the CD49fhi population, therewas a higher422 Stem Cell Reports j Vol. 8 j 417–431 j February 14, 2017proportion of SCA-1+ cells in the TEB (80%) compared with
the DUCT (10.53%) and TEB and DUCT-depleted (17.77%)
samples (Figures 5E–5G). Consistent with these findings,
analysis of the RNAs from isolated TEBs and ducts showed
that the TEBs were enriched for cell-cycle pathways (Table
S1) (Morris et al., 2006).
The CD24+ CD49fhi SCA-1+ Cells Express ERa
MaSCs have been shown previously to be ERaneg (Asselin-
Labat et al., 2006; Sleemanet al., 2007), andyetweobserved
a specific activation of mitotic activity in the CD24+
CD49fhi SCA-1+ cells at puberty. We reasoned they may be
responding to the hormonal surge at puberty and assessed
the expression of hormone receptors. ERa mRNA levels
and its target gene progesterone receptor (PR) were assessed
using qPCR in three biological pools of 20 mice each. As
anticipated, ERa was highest in the SCA-1+ luminal cells
and absent in the CD24+ CD49fhi SCA-1neg MaSC popula-
tion (Figure 6A) (Sleeman et al., 2007; Asselin-Labat et al.,
2006). The CD24+ CD49fhi SCA-1+ cells had 20-fold higher
levels of ERa at 3 weeks and 5-fold higher levels at 6 weeks
compared with CD24+ CD49fhi SCA-1neg cells (Figure 6A).
Figure 5. CD24+ CD49fhi SCA-1+ Are Enriched in Terminal End Buds
(A–D) Schematic of pubertal mammary glands with TEBs and a representative image of a TEB captured on a dissection microscope (A).
Representative FACS profiles of lineage depleted epithelial populations in TEB samples (B), TEB-depleted DUCTs samples (C), and TEB- and
DUCT-depleted samples (D).
(E–G) Representative flow cytometry profiles of SCA-1 populations within the CD24+CD49fhi populations of TEBs (E), TEB-depleted DUCTs
(F), and TEB- and DUCT-depleted samples (G).We further assessed ERa protein levels by sorting cells from
4-week-old mammary glands directly onto slides. Nuclear
ERa staining was observed in the CD24+ CD49fhi SCA-1+
cells (Figure 6B) (14% ERa positive) but not in the CD24+
CD49fhi SCA-1neg cells (Figure 6C). The positive control
luminal SCA-1+ cells showed high levels of nuclear staining
(Figure 6D) (49% ERa positive) compared with luminal
SCA-1neg cells (Figure 6E) (5% ERa positive). PR transcript
was relatively low in the luminal cells and CD24+ CD49fhi
SCA-1neg cells but increased 2-fold in 6-week-old CD24+
CD49fhi SCA-1+ cells compared with the CD24+ CD49fhi
SCA-1neg cells (Figure 6F).We also assessed the levels of Egfr and Rank/Rankl, as
these have been proposed to mediate hormone action in
MaSCs (Asselin-Labat et al., 2010). Egfr was highest in the
CD24+ CD49fhi SCA-1neg MaSCs at 3 weeks of age, while
the CD24+ CD49fhi SCA-1+ MaSC and luminal cells had
lower levels. At 6 weeks of age, Egfr remained high in the
CD24+ CD49fhi SCA-1neg cells but was also expressed in
SCA-1neg luminal cells at a similar level (Figure 6F). Rankl
and Rank receptor (Tnfrsf11a) are reported to be expressed
in the luminal and MaSC populations, respectively (Asse-
lin-Labat et al., 2010). In our study, Rankl was absent at
3 weeks of age and present only in the luminal cells atStem Cell Reports j Vol. 8 j 417–431 j February 14, 2017 423
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6 weeks of age. The Rank receptor was highest in the CD24+
CD49fhi SCA-1neg cells at 3 weeks of age, with appreciable
levels observed in CD24+ CD49fhi SCA-1+ and SCA-1neg
luminal cells. At 6 weeks of age, the pattern was similar;
however, the levels were highest in the CD24+ CD49fhi
SCA-1+ cells. Together our data indicate that CD24+
CD49fhi SCA-1+ cells present in the young mammary
glands possess some ERa and show PR expression, which
may render them sensitive to the pubertal hormone surge.
Since the CD24+ CD49fhi SCA-1+ cells expressed hor-
mone receptors, we determined if the genes identified
to be present within the CD24+ CD49fhi SCA-1+ and SCA-
1neg populations contained estrogen response elements
(ERE). We analyzed the mRNA sequence using both the
dragon ERE program and mined the existing data from a
genome-wide screen for high-affinity ERE in the mouse
and human genomes (Bourdeau et al., 2004). The latter
study used stringent cutoffs of two base deviations from
consensus, also a location of the ERE within 10 to +5 kb
of the transcriptional start site. The data were complemen-
tary. As shown in Figure 6G, EREs were not found within
the genes Aldh1, a-SMA, Delta1, Id4, Hes1, or Lgr5, all of
which were highly expressed in the CD24+ CD49fhi SCA-
1neg cells. Ly6a (Sca-1) was found to possess an ERE. EREs
were also identified within the notch target genes Hey 1
and Hey2, which were both expressed at high levels in
the CD24+ CD49fhi SCA-1+ cells, and in the notch receptor
ligand Jag1 (highest expression in CD24+ CD49fhi SCA-1+)
and in Fzd7 and p63, which were elevated in CD24+
CD49fhi SCA-1neg cells (Figure 6G). There was no ERE in
Mef2c, which was highly expressed in CD24+ CD49fhi
SCA-1+, but there was an ERE in the closely related Mef2d.
CD24+ CD49fhi SCA-1+ Cells Are Estrogen Responsive
The number of CD24+ CD49fhi SCA-1+ cells was highest
in pre-pubertal mice (Figure 1), indicating that they are
important in development. The high numbers in pre-pu-
bertal mice decreased at puberty and decreased further in
adult mice, consistent with estrogen responsiveness. We
measured the levels of CD24+ CD49fhi SCA-1+ and CD24+
CD49fhi SCA-1neg cells in three mouse models of estrogen
deficiency. The adult estrogen receptor a knockout mice
(Ex3aERKO mice) have a rudimentary ductal structureFigure 6. The SCA-1+ Subset Is ERa Positive
(A) ERa mRNA levels in mammary epithelial cell subpopulations at 3
(B–E) ERa protein levels in FACS-sorted populations from 4-week-old m
SCA-1+, (C) CD24+ CD49fhi SCA-1neg, (D) CD24+ CD49flo SCA-1+, (E) CD
(F) Mean fold change ± SEM of mRNA levels of PR, Rank, Rankl, and Egf
n = 3 pools of 20–30 animals. CD24+ CD49fhi SCA-1neg (pink bars), CD
bars), and CD24+ CD49flo SCA-1+ (light gray bars).
(G) Data for all high-affinity EREs in the mouse genome (Bourdeau et
The ERE needed to be only 2 base deviations from consensus as show(Hewitt et al., 2010) similar to that of a 3-week-old
mouse. Compared with age-matched post-pubertal wild-
type C57BL/6 mice with approximately 10%–20% CD24+
CD49fhi SCA-1+ and 80%–90% CD24+ CD49fhi SCA-1neg
cells (Figures 7A–7C), the CD24+ CD49fhi population of
Ex3aERKO mice was composed almost entirely (98%) of
CD24+ CD49fhi SCA-1+ cells (Figures 7D–7F). Similarly,
the CD24+ CD49fhi MaSC populations from ERa AF2 re-
gionmutatedmice (AF2ERKI) (Figure 7G) and from the aro-
matase-deficientmice (ArKO) (Figure 7H), which each have
only a rudimentary ductal gland phenotype, also possessed
largely CD24+ CD49fhi SCA-1+ cells. This is summarized in
Figure 7I. To see if the CD24+ CD49fhi SCA-1+ cells were es-
trogen sensitive, we treated ArKO mice with 17b-estradiol
pellets from post-natal day (P) 5 for 6 weeks. The 17b-estra-
diol supplementation led to increased mammary ductal
growth in the ArKOmice (Figure 7J) and resulted in a reduc-
tion in the number of the CD24+ CD49fhi SCA-1+ cells from
92% in placebo-treated ArKO mice to an average of 49%
(Figure 7K). To complement these results, adult (8-week-
old) wild-type C57BL/6 mice were treated with the ER
antagonist tamoxifen (n = 5/group). At 12 weeks, the
proportion of CD24+ CD49fhi SCA-1+ cells was signifi-
cantly increased in tamoxifen-treated versus control mice
(p = 0.0036; Figure S6).DISCUSSION
SCA-1 positivity identifies normal stem cells in many or-
gans, cancer stem cells in the breast (Burger et al., 2005;
Matsuura et al., 2004; Spangrude, 1989; Jo et al., 2009),
and LT-HSCs in blood (Osawa et al., 1996; Zhao et al.,
2000), yet its usefulness in isolating mouse MaSCs remains
controversial. Here, we found that SCA-1 could identify a
population within the CD24+/EpCAM+/CD49fhi MaSC-en-
riched population that had less repopulating activity than
the SCA-1neg counterparts but was ERa+ and estrogen
responsive. This ERa+ population of MaSCs was abundant
in young, but not old, mammary glands and was respon-
sive to endogenous and exogenous estrogens.
The results of this study show the SCA-1+ subset of the
CD24+ CD49fhi population is highest in young mice andand 6 weeks of age. *p < 0.05, **p < 0.01.
ice. ERa protein (red), DAPI nuclear stain (blue). (B) CD24+ CD49fhi
24+ CD49flo SCA-1neg.
r relative to 6 week CD24+ CD49fhi SCA-1neg sample normalized to 1,
24+ CD49fhi SCA-1+ (green bars), CD24+ CD49flo SCA-1 (dark gray
al., 2004) was mined. Stem cell markers containing EREs are shown.
n and within 10 to +5 kb of the transcriptional start site.
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decreases over time, in contrast to the CD49fhi SCA-1neg
and unfractionated CD49fhi cells, which are lowest in
3-week-old mice and increase with age. This appears to
contradict the theory that MaSCs are highest in young
mice, a theory based on the observation that TEBs, which
house theMaSCs (Bai and Rohrschneider, 2010) are at their
highest density in the mammary glands of young mice
(Russo and Russo, 1978a; Russo et al., 1982). In this study,
we have further challenged this theory by showing that
MaSCs are not enriched within the TEBs, with a small pro-
portion also found in the ducts of themammary gland. The
reason for an increase in CD24+ CD49fhi cell numbers with
age requires additional investigation, but is consistent with
emerging data showing that MaSCs are increased in older
animals (Huh et al., 2015; Plaks et al., 2013). We hypothe-
sized that the reduction of the SCA-1+ subset of the CD24+
CD49fhi population with age is in response to estrogen
signaling at puberty, stimulating a differentiation into
CD24+ CD49fhi SCA-1neg cells.
To confirm the SCA-1+ cells were not a contaminating
luminal population, we used SCA-1-GFP (Ly6A-GFP) mice
and assessed the gene expression profile of the SCA-1+ sub-
set compared with the SCA-1neg subset. We showed these
cells are not luminal progenitors, as they expressed pre-
dominantly basal markers. The CD24+ CD49fhi SCA-1+
cells showed expression of Delta1, a-SMA, and p63, all ab-
sent in the luminal cell populations. Aldh1a1, a marker of
SCA-1+ cancer stem cells, was higher in CD24+ CD49fhi
SCA-1neg cells than in the CD24+ CD49fhi SCA-1+ cells.
The CD24+ CD49fhi SCA-1+ cells did show high expression
of Notch receptor ligands and target genes (Jagged 1, Hes1,
Hey 1, Hey2), which are all more associated with differenti-
ated cells in the breast, but Hes1 has also been linked to LT-
HSCs.Mef2c is a transcription factor with identified roles in
cardiac morphogenesis and myogenesis. It is present in
human and mouse MaSCs (Cheng et al., 2000) and is also
present in LT-HSCs (Ficara et al., 2008) and was highly ex-
pressed in the CD24+ CD49fhi SCA-1+ cells. In additional,
the CD24+ CD49fhi SCA-1+ cells express high levels of
Notch1, which has been associated with differentiated cells,
but do not express high levels of the luminal marker
Keratin18. Furthermore, the CD24+ CD49fhi SCA-1+ cells
did not express high levels of Elf5 and C-kit and thusFigure 7. SCA-1+ Cells Are Estrogen Responsive
(A–H) The percentage of SCA-1+ and SCA-1neg cells within the CD24+
C57BL/6 (A–C), Ex3aERKO (D–F), AF2ERKI (G), and ArKO (H) mamma
(I) The mean percentage of SCA-1+ CD24+ CD49fhi cells in each mouse
(J) Mammary gland wholemounts from wild-type, ArKO, and ArKO+ es
ArKO mice.
(K) The mean percentage of SCA-1+ CD24+ CD49fhi cells within ArKO
n = 3–7.
*p < 0.05, **p < 0.01.cannot be luminal progenitor cells. Collectively, our gene
expression data indicate that the CD24+ CD49fhi SCA-1+
cells are basal cells with some expression of the previously
identified MaSC markers that we have found to be associ-
ated with the CD24+ CD49fhi SCA-1neg cells that have
the highest in vivo transplant activity. The expression of
some MaSC markers is in agreement with the limited
stem cell activity of these cells. Statistical significance was
not reached inmany cases due to the nature of the analysis
(three individual pools of 20–30 mice). This high number
of animals yielded only picogram amounts of RNA that
required amplification for gene expression analysis. With
only three samples, nonparametric analysis was used, as
we were unable to test for normal distribution of the
data. Our analysis is consistent with previous research us-
ing limited samples of MaSCs and differentiated luminal
cells (Bouras et al., 2008).
When we compared the in vivo MaSC activity using the
gold standardmammary fat pad transplant assay, we found
the CD24+ CD49fhi SCA-1neg cells had higher stem cell ac-
tivity than theCD24+CD49fhi SCA-1+ subset. Although the
stem cell activity of the CD24+ CD49fhi SCA-1+ cells was
limited (in vitro mammospheres and in vivo transplants),
theywere able to generate all the lineages, thereby fulfilling
a major requirement of an MaSC. However, they did not
have progenitor activity in vitro. Our data showing that
the SCA-1neg compartment has higher in vivo stem cell ac-
tivity is consistent with the work of Stingl et al. (2006) and
Shackleton et al. (2006) but contrasts with the work of
Welm et al. (2002), who showed SCA-1 enriched forMaSCs.
However, these early studies compared the SCA-1+ versus
negative epithelial cell compartments without prior selec-
tion on lineage or epithelial cells and so may be compli-
cated by the inclusion of nonepithelial cells. They were
unable to calculate the stem cell enrichment, as only six
transplants were completed and the cell inoculum varied.
Direct comparisons in the same laboratory with numerous
replicates at each dose are required to determine why these
differences occur.
In line with the aforementioned hypothesis that changes
with the SCA-1+ subset of the CD24+ CD49fhi population
with age is in response to estrogen signaling, we showed
that the CD24+ CD49fhi SCA-1+ cells are mitotically activeCD49fhi MaSC subset is shown in contour FACS plots from wild-type
ry glands.
strain at 6 weeks of age ± SEM, n = 3–5.
tradiol (E2) treatment. Boxed area highlights ductal growth in the
mice treated with either placebo or estradiol (ArKO + E2) ± SEM,
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at 6 weeks of age compared with the CD24+ CD49fhi
SCA-1neg cells. Interestingly, neither population has greater
than 0.1% of cells in G0 of the cell cycle at 6 weeks, indi-
cating that like the hematopoietic system (Cheng et al.,
2000), adult stem cells within the mammary gland are
not dormant.
ERa expression was confirmed to be significantly
increased in the SCA-1+ compared with the SCA-1neg
CD24+ CD49fhi population using both mRNA and protein
analysis, indicating direct estrogen responsiveness. Previ-
ous studies were unable to show ERa transcripts and very
limited protein in CD49fhi stem cells (Asselin-Labat et al.,
2006; Sleeman et al., 2007). We propose this was a conse-
quence of using 10- to 12-week-old mice, in which the
CD24+ CD49fhi SCA-1+ subset is quite low. However, Asse-
lin-Labat et al. (2006) did report that 0.01% of the MaSC
cells that they assessed had ERa expression, and thus it
may be that these rare cells were the SCA-1+ cells in the
MaSC pool.
As the CD24+ CD49fhi SCA-1+ cells decrease at puberty
but paradoxically express ERa, it was proposed that they
were negatively regulated by estrogen. This was confirmed
when estrogen-deficient mouse models (Ex3aERKO,
AF2ERKI, and ArKO) were assessed as adults (10–12 weeks
of age) and showed a high proportion of CD24+ CD49fhi
SCA-1+ cells. Adding support to this, treatment of ArKO
mice with estrogen shifted the proportion of CD24+
CD49fhi SCA-1+ cells into CD24+ CD49fhi SCA-1neg cells,
leading to an increase in mammary gland growth. Due
to this negative regulation of SCA-1+ cells by estrogen
overlapping with a period of high mitotic activity, we
postulate that these CD24+CD49fhi SCA-1+ cells are impor-
tant in ductal expansion of the mammary gland at pu-
berty. To investigate this point further, lineage tracing
will be required. Furthermore, since these cells are so
sensitive to changes in estrogen and are in such high
abundance in the young mammary gland, it implicates
them in the understanding of how hormone exposure
can mediate BCa risk many decades after exposure. If the
CD24+ CD49fhi SCA-1+ cells are also shown to be the
most carcinogen sensitive, it may explain why carcino-
genic exposure in younger women has the most delete-
rious impact on BCa risk later in life. Intriguingly, HSCs,
which are also SCA-1+, undergo more frequent self-renew-
ing divisions in females compared with males, which
Nakada et al. (2014) recently proved could be mediated
by estrogen. Estrogen was also shown to be critical for
the mobilization of proliferating HSCs to the spleen and
expansion of splenic erythropoiesis during pregnancy
(Nakada et al., 2014).
In line with their estrogen responsiveness and activation
of the cell cycle at puberty, the CD24+ CD49fhi SCA-1+ cells
were found to be enriched in TEBs. TEBs are highest in the428 Stem Cell Reports j Vol. 8 j 417–431 j February 14, 2017pubertal animal and are considered the proliferative unit
of the developing gland (Russo and Russo, 1978a, 1978b,
1980). This agrees with our data showing that the SCA-1+
TEBS are abundant and actively cycling at puberty. TEBs
have been associated with the carcinogen sensitivity of
the mammary gland, yet whether the stem cells or the pro-
liferative nature of the TEBs is responsible is unclear (Russo
et al., 1979). Our data indicate that the proliferating SCA-1+
subset of MaSCs within the TEBs are likely mediating the
carcinogen sensitivity.
Here, we have characterized an ER-positive and estrogen-
sensitive population within the CD24+ CD49fhi MaSC-
enriched compartment. Mammary repopulating activity,
while present, does not appear to be a predominant func-
tion, instead their abundance in the young mammary
gland and estrogen sensitivity indicate a role in pubertal
mammary development and hormonal sensitivity early
in life.EXPERIMENTAL PROCEDURES
Animals and Breeding Experiments
Animal experimentswere completed under approval fromMonash
University Animal Ethics Committee, Peter MacCallum Cancer
Centre Animal Ethics Committee, Animal Ethics Committee of
Florey Institute or under the UK Animals Scientific Procedures
Act 1986. MaSCs were isolated from fourth mammary fat pads of
FVB/n mice at 3, 6, 9, and 25 weeks of age for the age, transplant,
and qPCR experiments. LGR5-GFP mice (B6.129P2-Lgr5tm1 (cre/
ERT2)Cle/J) were a kind gift from Hans Clevers (Barker et al.,
2007). ERa knockout (Ex3aERKO), ERa AF2 domain dysfunctional
(AF2ERKI) (Arao et al., 2011), aromatase-deficient (ArKO) (Fisher
et al., 1998), and Ly-6A (SCA-1) GFP transgenic mice (Alvi et al.,
2003) have all been described before. All mice were housed under
specific pathogen-free conditions. ER- and aromatase-deficient
mice weremaintained on a soy-free diet (Specialty Feeds), with un-
detectable levels of isoflavones (Soyfree), as dietary phytoestrogens
have been shown to be estrogenic in estrogen-deficient mice (Britt
et al., 2002).
Isolation, Staining, and Flow Cytometric Analysis of
Mouse Mammary Cells
MaSCs were isolated using mechanical and enzymatic digestion
followed by fluorescence-activated cell sorting (FACS), as detailed
previously (Asselin-Labat et al., 2006; Sleeman et al., 2007). Cells
were stained with either anti-CD24 Pacific Blue (catalog no.
582583; BD Biosciences) or EpCAM BV605 (catalog no. 563214;
BD Biosciences), CD31 (catalog no. 561410)/CD45 (catalog no.
552848)/TER119 (catalog no. 557853) Pe Cy7 (BD Biosciences),
Ly6A-PE (catalog no. 553108, BD Biosciences), and CD49f-APC
(catalog no. 313616, Biolegend). Linear density contour plots
were used to determine gates for stem cell populations. FMO stain-
ing control samples were used to determine the gates for SCA-1-
negative cells. Flowlogic was used to analyze data and prepare
figures.
Isolation of Mammary TEBs and Ducts
TEB and duct isolation was performed as previously (Morris et al.,
2004) with modifications. Mammary glands were collected from
FVB/n mice at 5–6 weeks of age and coarsely chopped in a Petri
dish using scalpel blades before incubation in digest mixture
(1 mg/mL collagenase 1 [Worthington] in 10 mL of serum-free
L15) at 37C for 25 min. Following this, the tube was vigorously
shaken, and the digest mix was split into two 50 mL Falcon tubes.
Tubes were made up to 50 mL with serum containing L15. The
tubes were then briefly centrifuged, and the pellets from each
tube were combined and centrifuged again before placing onto a
gridded 35 mm Petri dish (Thermo Scientific) under a dissecting
microscope. Using a 10 mL pipette set to 2 mL, TEBs and ducts
were gently sucked up the pipette tip and placed into serum con-
taining L15. Within an hour, TEB and ducts were gently trypsi-
nized to obtain single cells and stained for flow cytometry.
Limiting Dilution Fat Pad Transplantation Assays and
Outgrowth Confirmation
MaSCs were isolated from 6-week-old nulliparous animals for
comparison of the CD24+ CD49fhi SCA-1neg and CD24+ CD49fhi
SCA-1+ populations. MaSCs were collected into serum containing
L15 medium (Invitrogen) and immediately resuspended in
serum-free L15 at the required concentration. Fresh cells were
transplanted into cleared fat pads of 3-week-old mice as described
previously (Britt et al., 2009). After 10 weeks, the reconstituted fat
pads were removed and assessed by carmine-stained whole-
mounts. All outgrowths were dissected and processed into paraffin
blocks for confirmation of structure and cell lineage analysis by
immunohistochemistry. Keratin 14/18 dual immunofluorescence
was completed as described previously (Britt et al., 2009). All sec-
tions were examined on a Nikon C1 confocal microscope, Invert,
based onNikon Eclipse Ti and captured using the NIS Elements Ni-
kon acquisition software. Single antibody-stained control sections,
where either the primary antibody was absent or was combined
with an inappropriate secondary antibody, were used to confirm
the specific staining. ERa staining was completed as described
previously (Britt et al., 2009). The MaSC enrichment within each
population was determined using the extreme limiting dilution
statistical analysis program (Hu and Smyth, 2009).
Cell-Cycle Analysis Using Hoechst 33342 and Ki67
To distinguish cells inG0/G1 from cells inG2/S/M, the samples were
stainedwith theDNAbindingdyeHoechst 33342 andKi67 todelin-
eate G0 from G1 since Ki67 is not present in noncycling (G0) cells
(Mullally et al., 2013). All cells were immunostained for lineage
markers mentioned above before fixing and permeabilizing with a
Fix and Perm Kit (Invitrogen). Simultaneous staining of Ki67 (clone
B56, catalog no 556003; BD Biosciences) 1:20 in reagent B of the
Fix and Perm Kit was completed at room temperature for 30 min.
Cells were washed in PBS/0.1% NaN3/5% fetal bovine serum (FBS),
spun down at 35003 g for 5 min, and resuspended pellet in Hank’s
balanced salt solution with 20 mM HEPES, 10% FBS, 1 mg/mL
glucose, and 6.16 mg/mLHoechst 33342 (catalog no.H1399;Molec-
ular Probes) and incubated for 30min at room temperature. Finally,
the cells were washed and resuspended in Lebovitz’s/10% FBS and
analyzed by flow cytometry on an LSRIIb (BD Biosciences).RT-PCR Analysis
RNA was isolated from flow-cytometry-sorted cell populations us-
ing the RNeasy Micro Kit (QIAGEN) following the manufacturer’s
instructions. RNA content was quantitated using the Qubit 2.0
Fluorometer (Invitrogen) and quality was determined using a
2100 Bioanalyzer (Agilent Technologies). cDNA was synthesized
by reverse transcription using Superscript III, random primers,
and dNTPs (Invitrogen) and pre-amplified with TaqMan PreAMP
mastermix (Applied Biosystems) as per themanufacturer’s instruc-
tions. qRT-PCR was completed using TaqMan probes on a 7900HT
Thermocycler (Applied Biosystems) in a reaction consisting of
50 ng of cDNA, 0.5 mL of TaqMan probe, 5 mL of TaqMan Advance
Mastermix, 3 mL of H2O under the following conditions: 50
C for
2 min, 96C for 20 s, 95C for 1 s, and 60C for 20 s, with 40 cycles
of the last two conditions. The data were analyzed using SDS
version 2.3 software. Relative expression of each probe to house-
keeping probe 18S in each sample was determined using the
2DDCT method. Samples were normalized and compared with the
6 week CD24+ CD49fhi SCA-1neg control. The relative gene expres-
sion levels were analyzed using GraphPad Prism. A normality test
could not be completed (three biological replicates of n = 20 pooled
mice), and thus a nonparametric Kruskal-Wallis test with Dunn’s
multiple comparisonwas used. p Values less than 0.05were consid-
ered statistically significant. Table S2 shows the TaqMan primers
used for these studies.ERa Immunofluorescence Staining
FACS-sorted cells were cytospun onto Superfrost Plus glass slides
(Menzel-Gla¨ser) at 600 rpm for 3 min using a Shandon Cytospin
3 (Thermo Scientific). The cells were then fixed onto the slides in
PBS/4% paraformaldehyde for 10 min at room temperature. Cells
were then permeabilized for 2 min in PBS/0.15% Triton-X 100
(Sigma) and blocked O/N in PBS/1% BSA (Amresco) at 4C. The
following day, ERa anti-mouse monoclonal antibody (ID5 clone,
catalog no. M7047; Dako) was added at 1:50 in PBS and incubated
for 1 hr at room temperature. Cells were then washed in
Tris-buffered saline (TBS)/0.1% Tween 20, before secondary anti-
body (anti-mouse immunoglobulin G1, 555) was added and incu-
bated at room temperature for 1.5 hr. Cells were then washed in
TBS/Tween 20 0.1%, counterstained with 5 mg/mL DAPI (3 3
5-min washes), mounted in Vectashield mounting-media (Vecta-
labs), and cover-slipped for imaging.Stem Cell Analysis in Estrogen-Deficient Mice
To determine if the CD24+ CD49fhi SCA-1+ cells were estrogen sen-
sitive, we assessed the MaSC populations present in the ERa-defi-
cient Ex3aERKO mice (Hewitt et al., 2010), in the ERa dysfunc-
tional AF2ERKI mice (mutations in the AF2 activation function
domain of ERa) (Arao et al., 2011), and in estrogen-deficient
ArKO mice (Fisher et al., 1998). ArKO mice and wild-type mice
were treated with 0.2 mg of silastic 17b-estradiol or saline placebo
pellets implanted into the dorsal flank from P5 to P47.
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